MYCOBUTIN
MYCOBUTIN
Approved
DIN Number
02063786
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02063786
AIG Number0124092001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04AB04 RIFABUTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:16.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIFABUTINActive
Strength: 150 MG
Monograph: RIFABUTIN